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Abstract
Cellular differentiation involves widespread epigenetic reprogramming, including modulation of DNA methylation patterns.
Using Differential Methylation Hybridization (DMH) in combination with a custom DMH array containing 51,243 features
covering more than 16,000 murine genes, we carried out a genome-wide screen for cell- and tissue-specific differentially
methylated regions (tDMRs) in undifferentiated embryonic stem cells (ESCs), in in-vitro induced neural stem cells (NSCs) and
8 differentiated embryonic and adult tissues. Unsupervised clustering of the generated data showed distinct cell- and tissue-
specific DNA methylation profiles, revealing 202 significant tDMRs (p,0.005) between ESCs and NSCs and a further 380
tDMRs (p,0.05) between NSCs/ESCs and embryonic brain tissue. We validated these tDMRs using direct bisulfite
sequencing (DBS) and methylated DNA immunoprecipitation on chip (MeDIP-chip). Gene ontology (GO) analysis of the
genes associated with these tDMRs showed significant (absolute Z score.1.96) enrichment for genes involved in neural
differentiation, including, for example, Jag1 and Tcf4. Our results provide robust evidence for the relevance of DNA
methylation in early neural development and identify novel marker candidates for neural cell differentiation.
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Introduction
DNA methylation occurs predominantly as covalent modifica-
tion of cytosines within a CpG sequence context. It represents the
most stable epigenetic mark and has an impact on different
biological processes in both healthy and diseased cells, including
e.g. neural cell differentiation [1,2,3]. Large-scale DNA methyl-
ation profiling has demonstrated that tissue-specific differentially
methylated regions (tDMRs) are highly correlated with cellular
phenotypes [4,5,6]
Much effort has been made to understand the dynamics of
DNA methylation during neural cell differentiation and the
identification of epigenetic biomarkers that capture different
aspects of cellular differentiation processes. ESCs are of particular
interest in this context as they have previously been shown to
acquire characteristic epigenetic marks during their differentiation
from ESCs to NSCs and, subsequently, to tissues [7,8]. Probably
the best-known marker of neural cell differentiation is Pou5f1
(usually referred as Oct4), encoding a homeobox protein essential
in the maintenance of pluripotency [9]. A tDMR at this gene is
hypomethylated in ESCs and hypermethylated in NSCs and
terminally differentiated tissues [10]. In a recent targeted study, we
reported a tDMR in the body of the Ddah2 gene to be an
epigenetic biomarker for neural stem cell differentiation [11].
Here, we conducted a genome-wide study to generate and analyze
DNA methylation profiles of E.14 embryonic stem cells (ESCs)
and in vitro induced neural stem cells (NSCs), as well as 4
embryonic and 4 adult murine tissues using a custom mouse DMH
array.
Numerous methods have been developed for genome-wide
DNA methylation profiling [12,13]. Among them, Differential
Methylation Hybridization (DMH) allows the detection of tDMRs
by digesting genomic DNA into a defined fragment library using
first methylation-insensitive restriction enzymes, adaptor ligation,
digestion of unmethylated template fragments using methylation-
sensitive restriction enzymes, adaptor-mediated amplification and
subsequent hybridization to microarrays [14,15]. By coupling this
technology to custom-designed arrays, genome-wide coverage of
DNA methylation profiles can be achieved [16]. Recently, we
developed a mouse-specific DMH array that contains 51,243
features covering 17,384 genes and 16,656 promoter regions
distributed across all chromosomes. Our results highlight the
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differentiation and identify novel candidate markers for neural
cell differentiation. Furthermore, as our data are compatible with a
human-specific DMH array these results potentially enable an
extrapolation to orthologous human genes.
Results
Tissue-specific DNA methylation profiles using DMH
We studied the DNA methylation profiles of E.14 ESCs and in
vitro induced NSCs derived from this cell line [11], representing
totipotent and pluripotent cellular development stages, respective-
ly, 4 embryonic mouse tissues (limbs, spinal cord, forebrain and
hindbrain) representing cells at a differentiated embryonal
development stage, and 4 adult mouse tissues (spleen, liver, kidney
and heart) representing terminally differentiated cells. In addition,
we included enzymatically methylated (100% methylation) and
unmethylated (0% methylation) control samples. These controls
serve as calibrators for the quantification of the relative
methylation value for each of the 51,243 features on the array.
We generated and analyzed DNA methylation profiles using the
DMH technology as described previously [15], but on a newly
designed custom mouse array.
To explore the DNA methylation distribution across the murine
genome, we studied the relationship between the feature location
and methylation content in all samples (Figure 1). After array
normalization and data processing, the full DMH dataset
contained 51,243 features. Of these, 23,957 features were
associated with Transcription Start Sites (TSS) of annotated genes
and 27,286 were located in distal CpG rich areas (Figure 1A). The
average methylation values of the features located within a range
of 1000 bases upstream or downstream to the TSS were low (20%
average methylation). Features located outside this range showed
increasing methylation values towards hypermethylation
(Figure 1B). The majority of TSS-associated features had low
methylation scores (,10%) while features not associated with TSS
showed higher values towards hypermethylation (.75%). We did
not detect differences in the average methylation between the
samples studied when the features were located in non-coding (i.e.
promoter) or coding (i.e. exon 1 or intron 1) regions, regardless of
their association with TSS (Figure 1C). To study the differences in
DNA methylation distribution in individual tissues and cells, we
compared the methylation percentage distribution in ESCs, NSCs
and embryonic brain (Figure 1D). DMH scores in these samples
have a bimodal distribution, with one peak corresponding to
unmethylated features (0% methylation) and the other peak
corresponding to hypermethylated features (100% methylation).
While ESCs and NSCs displayed similar distributions with well-
differentiated peaks, the distribution in embryonic brain is shifted
towards more intermediate values.
DNA methylation profiles of ESCs, NSCs and embryonic
brain
We studied the variation of DNA methylation profiles among
ESCs, NSCs and embryonic brain and analyzed the data to
identify candidate markers which potentially play a role during
neural cell differentiation. First, we separated the features on the
DMH array according to their association to the TSS. Hence, we
obtained two independent datasets that can be interpreted
independently. In this study, we focused on TSS-associated
features. Similar analyses were also performed on non TSS-
associated features (data not shown).
Figure 1E shows a volcano plot identifying differentially
methylated regions between NSCs and ESCs. We ranked all
features according to the effect size of the differential methylation
(M) and the T- statistic (T) values and selected candidate tDMRs.
The complete list of tDMRs and their associated genes are
provided in the supplementary information (Supplementary Table
S1). Out of the 202 top-ranked tDMRs, 140 displayed higher
methylation in NSCs versus ESCs while 62 displayed the opposite
pattern, i.e. higher methylation in ESCs and lower in NSCs
(Figure 2).
Next, we studied if the identified tDMRs were related to the
degree of neural differentiation. We selected 382 candidate
tDMRs according to the following criteria: p-value lower than
0.05, effect size higher than 0.5 and minimum DMH score higher
than 0.5 in at least one group. Unsupervised clustering of these
candidates revealed distinct groups among NSCs, ESCs and
embryonic brain samples (Figure 3A). Variance analysis (AN-
OVA) of the methylation percentage defined 6 tDMR groups
(Figure 3B). For example, group 1 contained 84 tDMRs which
were highly methylated in NSCs but unmethylated in ESCs and
embryonic brain. Among the genes associated with the tDMRs in
group 1, we found genes related to stem cell differentiation
(Sox10) and cell proliferation (Lhx9, Gbx2, Emx2), as well as genes
related to the development of the brain and the neural system
(Gbx2, Tbr1, Slit2, Sema6a). The complete list of tDMRs in each
group and their associated genes are provided in supplementary
table S2.
Taken together, our data strongly suggest that DNA methyl-
ation may play a major role during murine neural stem cell
differentiation. To explore whether the genes associated with
tDMRs were functionally related, we used the MAPPFinder
software [17] to assess the Gene Ontology (GO) groups
overrepresented among them. Supplementary table S3 contains
the MAPPFinder results for these tDMR-associated genes ranked
by their corresponding Z-score. Groups over-represented in genes
associated with tDMRs that were highly methylated in ESCs,
were mostly related to brain and central nervous system
development (e.g. ‘‘nervous system development’’, GO ID:
7399, 7/15 included genes, Z-score: 1.945) and regulation of
gene expression (e.g. ‘‘transcription’’, GO ID: 6350, 10/23
included genes, Z-score: 2.884). Conversely, many groups over-
represented in genes associated with tDMRs that were highly
methylated in NSCs, were related to membrane and lipid
metabolism (i.e. ‘‘cellular lipid metabolic process’’, GO ID:
44255, 5/5 genes changed, Z-score: 1.546) and phosphatase
activities (e.g. ‘‘nucleoside-triphosphatase activity’’, GO ID:
17111, 5/5 genes included, Z-score: 1.546).
Validation of candidate tDMRs using direct bisulfite
sequencing
To validate the tDMRs identified by murine-specific DMH with
a different technology, we used direct bisulfite sequencing (DBS)
[4,18,19]. We selected 51 tDMRs (see Supplementary Table S2),
choosing predominantly candidates with large effect sizes in the
ANOVA analysis and including candidates that were either
hypermethylated or hypomethylated in ESCs.
DBS validation of these 51 tDMRs was done on amplicons from
five different biological samples: ESCs, NSCs, embryonic neural
tissue (spinal cord and dorsal root ganglia), adult neural tissue
(cerebellum and spinal cord) and adult non-neural tissues (liver
and skeletal muscle) (Figure 4A). To evaluate the correlation
between DMH and DBS quantitatively, we compared the
averaged methylation values obtained by DMH and DBS on the
same biological samples using ESC, NSC and adult liver
(Figures 4B, C and D). The correlation coefficient was 0.679
when all DMH features/DBS amplicon pairs were considered.
Methylome Profiling in Neural Differentiation
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site the correlation coefficient decreased to 0.438 (Figure 4C). The
observed methylation data distribution was comparable with both
technologies (Figure 4D) showing a bimodal distribution with
peaks for unmethylated (0% methylation) and for fully methylated
(100% methylation) amplicons or DMH features, respectively.
Correlation between DMH and MeDIP data
In a previous study, we used an affinity capture method
(MeDIP-chip) to screen mouse chromosome 17 for neural
differentiation biomarkers in ESCs and NSCs [11]. Taking
advantage of the fact that MeDIP-chip and DMH profiling was
performed on the same biological samples; we compared the
methylation values in regions of particular interest obtained with
both technologies.
Of the 202 genes associated with the top-ranking tDMRs from
the DMH analysis of NSCs and ESCs, 8 were also included on the
MeDIP array (Table 1). Of these, 6 genes (Pou5f1, Ddah2, Nr4a2,
Itpka, Btbd17 and Emx2) were hypermethylated in NSCs, while 2
genes (Fam179a and Fbxl17) were hypermethylated in ESCs. We
focused our analysis on two genes that have been reported as
epigenetic biomarkers for neural stem cell differentiation: Pou5f1
[20] and Ddah2 [11]. Figure 5A shows the location of the features
covering the investigated regions on the DMH (red boxes) and
MeDIP (green boxes) arrays for Pou5f1 (upper panel) and Ddah2
(lower panel), respectively. For the Pou5f1 gene, we studied two
regions covering the exon 1-intron 1 junction (Region 1) and
intron 1 (Region 2), respectively. We studied 3 regions for the
Ddah2 gene, Region 3 covering the exon 1-intron 1 junction and
Regions 4 and 5 located within the gene body. In general, the
results obtained by DMH and MeDIP-chip were comparable for
these regions. For example, we detected differential methylation in
Region 2 by both methods, DMH and MeDIP (Table 1 and
Figure 5B). This region was intermediately methylated in ESCs
(65% and 38%, for DMH and MeDIP, respectively), while highly
methylated in NSCs (91% and 42%). Likewise, Region 2 was
lower methylated in ESCs (4% and 3%) than in NSCs (45% and
19%). We detected differential methylation only in the gene body
of the Ddah2 gene but not at the 59 end of the gene (Figure 5B,
lower panel) by both methods. At the 59 end of the gene, Region 3
showed lower methylation in both, ESCs (11% and 10%) and
NSCs (14% and 13%). In the gene body, however, Regions 4 and
5 showed higher methylation in NSCs than in ESCs. Region 4 was
unmethylated in ESCs (3% and 34%) while moderately methyl-
ated in NSCs (21% and 47%). Region 5 was moderately
methylated in ESCs (21% and 23%), while intermediately
methylated in NSCs (60% and 67%). However, we detected
differential methylation in Region 1 within the Pou5f1 gene only by
DMH.
Discussion
DNA methylation profiles obtained by DMH allow
differentiation of tissue and cell types in mouse
The high genomic coverage of our DMH microarray platform
enabled the evaluation of genome-wide profiles, showing charac-
teristic features of DNA methylation across the murine genome in
tissues and cell lines. In general, the profiles showed the classical
bimodal distribution with peaks at 0% and 100% methylation
relative to methylated control DNA, respectively. However, tissues
showed an increased number of intermediate DNA methylation
values. As tissues have a more heterogeneous cellular composition
than cell cultures, DNA methylation values will correspond to the
average values across different cell types and their degree of
differentiation. In addition, we observed mainly hypomethylation
of regions neighbouring the TSS and increased methylation
content in distal regions of coding and non-coding regions. This is
in line with the distribution of methylation observed in human
studies [4,21,22]. In a previous work, we reported a high
correlation between the tissue specific differential methylation in
human and mouse [4]. As the murine DMH microarray contains
orthologous regions to those contained in our human DMH
microarray, results can potentially be extrapolated to similar
studies using human tissue and cell samples. The corresponding
annotation between orthologous genes enables comparative
genome-wide epigenetic profiling in animal models; as would be
required, for example, in the pre-clinical evaluation of drug effects
and toxicity. Furthermore, the DMH profiles of terminally
differentiated mouse tissues presented in this study represent a
comprehensive and valuable dataset which will be subjected to
more detailed investigation of tissue-specific DNA methylation
differences in a future study.
Although we can not rule out the possibility that some of the
observed differences between ESCs and NSCs and adult and
embryonic tissues are due to different genetic backgrounds, our
previous findings suggest that specific DNA methylation differ-
ences in non-malignant tissues are more frequent and pronounced
than methylation differences due to inter-individual differences
[4]. In this regard, studies comparing inbreed mice generally focus
on phenotypical traits that can be attributed to genetic differences
[23,24], rather than the study of overall variation in DNA
methylation profiles in similar tissues of different mice strains.
Schilling and colleagues reported 435 regions associated to 171
genes showing strain-specific DNA methylation, when DNA
methylation profiles of macrophages from C57BL/6 and BALB/
c were compared [25]. However, it should be considered that the
studied regions in that work were selected from differential
expression patterns that might explain the immunological
differences between these two strains and therefore, extrapolation
Figure 1. DNA methylation data distribution. A) DMH feature location across the genome. After array normalization and data processing, the
full DMH dataset contained 51,243 features. Thereof, 23,957 features were associated with Transcriptional Start Sites (TSS) of annotated genes, 27,286
were located in distal CG rich areas. B) TSS-associated features (+/21 kb range) are less methylated with respect to features not associated with TSS.
The red line represents the average methylation percentages (Y-axis) in all tissues and cells across DMH features sorted by their distance to the TSS (X-
axis). C) Methylation distribution was similar in coding and non-coding regions in features associated to TSS (left panel) and features not associated to
TSS (right panel). Distribution of features located in coding and non-coding regions are represented as green and gray shapes, respectively. DMH
scores represent the percentage of methylation calculated using enzymatically methylated (100% methylation) and unmethylated (0% methylation)
control samples as calibrators. Thus, DMH scores range from 0 to 1, representing 0% and 100% methylation, respectively D) ESCs, NSCs and
embryonic brain samples showed bimodal distribution with peaks at 0 (0% methylation) and 1 (100% methylation). While ESCs and NSCs displayed
similar distribution with well-differentiated peaks, embryonic brain distribution is shifted towards more intermediate values. Distribution of DMH
scores in NSCs, ESCs and embryonic brain are represented as blue, green and red lines, respectively. E) Volcano plot of features showing differential
methylation in ESCs and NSCs. 140 regions were highly methylated in NSCs and 62 highly methylated in ESCs. Features were ranked and candidate
tDMRs were selected following the criteria detailed in the text. X-axis represents the methylation percentage difference between ESCs and NSCs while
Y-axis represents the registered t-statistic for that difference. Red circles highlight candidate tDMRs. Features showing higher methylation in NSCs
and ESCs are clustered on the right and left sides, respectively.
doi:10.1371/journal.pone.0026002.g001
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variation of the DNA methylation profiles. The extent of
epigenetic variation that can be attributed to genetic differences
have been studied in humans using monozygotic and dizygotic
twins. Kaminsky and colleagues showed that matched monozy-
gotic twins had significantly higher intraclass correlations than
dizygotic twins [26]. In the same study, they did not detect
significant variation in the distribution of DNA methylation
Figure 2. TSS-associated tissue-specific differentially methylated regions (tDMRs) in stem cells and embryonic tissues. 202 candidate
tDMRs were discovered comparing profiles in NSCs and ESCs. Each row corresponds to a feature in the DMH array while each column corresponds to
a sample, i.e. NSCs (n=2), ESCs (n=2) embryonic and adult tissues (n=8). Quantitative methylation analysis results are shown in a color code ranging
from yellow (,0% methylation), over green (,50% methylation) to dark blue (,100% methylation).
doi:10.1371/journal.pone.0026002.g002
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genomic regions using a methylation-sensitive enzymatic restric-
tion strategy coupled to microarray. Taken together these findings
support the idea of epigenetic variation originating at the zygote
stage, without being limited to DNA sequence variation. In order
to reach more comprehensive insights, a combined study using
unbiased and high-coverage approaches for sequencing (i.e. deep
sequencing) and DNA methylation profiling (i.e. DMH or MeDIP)
in non-malignant tissues of different mouse strains will be required.
The comparison of DMH and DBS data for differentially
methylated regions resulted in a correlation of 68%. This
correlation, however, decreased to 44% when the DMH features
contained only a single DNA methylation-sensitive restriction site.
In DBS amplicons corresponding to DMH fragments with a single
restriction site, only the methylation value for the CpG within the
site is considered. When DBS amplicons corresponded to DMH
fragments containing multiple restriction sites, methylation values
were averaged for the CpGs included in those sites.. Therefore, we
expect that fragments with single restriction sites may be more
sensitive to variability, due to intrinsic sample factors, technical
performance or other experimental parameters. As the proportion
of fragments containing single and multiple restriction sites
fragments in our DBS analysis (19 vs. 29; Figure 4B) is similar
to the overall representation of these fragments on the DMH
array, differences in the correlation coefficients between fragments
with single and multiple restriction sites are probably not caused
Figure 3. TSS-associated tDMRs define distinct groups in NSCs, ESCs and embryonic brain. A) Unsupervised clustering of top-ranked
candidates. B) ANOVA of methylation percentage in ESCs, NSCs and embryonic brain defined 6 tDMR groups. 382 candidate tDMRs were selected and
ranked. Color code as detailed in Figure 2.
doi:10.1371/journal.pone.0026002.g003
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PLoS ONE | www.plosone.org 7 October 2011 | Volume 6 | Issue 10 | e26002Figure 4. tDMR validation by direct bisulfite sequencing. A) Averaged methylation values obtained by direct bisulfite sequencing (DBS). 51
candidate regions were studied in embryonic stem cells (ESCs), neural stem cells (NSCs), embryonic spinal cord (EmbSC), embryonic dorsal root
ganglia (EmbDRG), adult cerebellum (AdCer), adult spinal cord (AdSC), adult liver (AdLiv) and adult skeletal muscle (AdSM). Color code as detailed in
Figure 2. Rows represent each DBS amplicon and columns correspond to the average methylation value per sample type. B) DMH methylation
percentage and averaged DBS amplicon methylation values in NSCs and ESCs. 49 matched DMH features/DBS amplicons were studied in the same
biological samples. Data are presented in two color-matching matrices for DMH and DBS (left and right matrix, respectively). The numbers in brackets
next to each feature ID indicate the number of restriction sites in the respective DMH fragments. Rows represent each DMH feature or DBS amplicon
and columns correspond to the average methylation value per sample type. Color code as detailed in Figure 2. C) Correlation analysis of DMH and
DBS data. Mean CpG methylation obtained by DBS are shown on the X-axis and DMH scores are showed on the Y-axis. The correlation coefficient was
0.679 for all DMH features/DBS amplicon pairs, while 0.438 for pairs for which the DMH feature contained a single restriction site. Points in circles
highlight features with a single restriction site. D) DNA methylation data distribution in DMH features and DBS amplicons. Data distribution was
similar with both technologies. The blue line represents the distribution of the DMH scores while the green line the distribution of mean DNA
methylation for DBS amplicons.
doi:10.1371/journal.pone.0026002.g004
Table 1. DNA methylation values assessed by DMH and MeDIP-chip.
DMH methylation MeDIP-Chip methylation
Associated gene DMH feature NSCs (%) ESCs (%) MeDIP probeset NSCs (%) ESCs (%)
Pou5f1 (Oct 4) – Region 1 EpiMusI6454361Q 91 65 CHR1700P033607569 39 41
CHR1700P033607659 39 41
CHR1700P033607744 43 39
CHR1700P033607849 46 34
Pou5f1 (Oct 4) – Region 2 EpiMusI6454364Q 45 4 CHR1700P033608465 22 3
CHR1700P033608535 22 3
CHR1700P033608620 14 4
Ddah2 - Region 3 EpiMusi6452854Q 11 14 CHR1700P033156327 8 9
CHR1700P033156387 8 9
CHR1700P033156487 16 22
Ddah2 - Region 4 EpiMusI6452858Q 21 3 CHR1700P033157456 17 22
CHR1700P033157546 25 29
CHR1700P033157631 56 44
CHR1700P033157701 63 45
CHR1700P033157781 75 31
Ddah2 - Region 5 EpiMusI6452859Q 60 21 CHR1700P033157891 73 25
CHR1700P033157956 65 23
CHR1700P033158046 65 23
Nr4a2 EpiMusI621364Q 100 11 CHR200P057112628 67 61
CHR200P057112693 44 42
CHR200P057112803 73 66
Itpka EpiMusI843026Q 98 29 CHR200P119484622 55 32
CHR200P119484712 52 31
CHR200P119484777 49 29
Btbd17 EpiMusI9044297Q 100 11 CHR1100P114900476 78 24
CHR1100P114900556 35 46
CHR1100P114900656 24 44
CHR1100P114900731 35 22
Fbxl17 EpiMusI6552624Q 7 100 CHR1700P061493554 21 93
CHR1700P061493659 34 92
CHR1700P061493719 38 90
Fam179a EpiMusI6582932Q 1 70 CHR1700P069972763 23 61
CHR1700P069972863 15 58
CHR1700P069972963 13 55
Emx2 EpiMusI7165730Q 80 10 CHR1900P059382729 27 10
doi:10.1371/journal.pone.0026002.t001
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restriction sites. The lower correlation coefficient does not
diminish, however, the concordance rate in an important number
of new marker candidates, as can be seen in Figure 4D and table
S1. Likewise, when we compared the results from our previous
work with these cells [11], we found concordant results between
mouse DMH and MeDIP not only for the neural differentiation
markers, Pou5f1 and Ddah2, but also for other loci that were
covered by both arrays. Since these technologies use different
approaches for methylation detection (restriction enzymes, sodium
bisulfite conversion and antibody against 5-MeC, for DMH, DBS
and MeDIP respectively), the concordance highlights the strength
of the findings. However intrinsic technical limitations as discussed
by Irizarry and colleagues [27] cannot be excluded.
For many features we observed DMH scores higher than 1
(representing 100% methylation, as extrapolated by methylated
control sample signals). There are three possible major sources for
such measurements. 1) The variance around 100% is much larger
than in the lower methylation range. As DMH utilizes a genome-
wide PCR, it might lead to broader peaks at the fully methylated
side of the mainly bimodal methylation distribution and thereby,
extending the extrapolated rates beyond 100%. 2) The enzymat-
ically methylated reference DNA might partially be incompletely
methylated, which would lead to an over-estimation at the affected
sites. 3) Since DHM assesses the total amount of methylated DNA,
an increase in the copy number of a methylated region will also
lead to an increased amount of detected DNA and therefore to a
significantly higher methylation percentage. Thus, tissue- specific
copy number increases with respect to the 100% calibrator DNA
(hypermethylated control, defined as 100% methylation) will result
in scores higher around than 1.5 for copies in triplicate and
beyond for sites with multiple copies. Thereby, it is very likely that
linear interpolation to estimate the exact copy number is not
possible with data from the DMH array used in this study.
Interestingly scores beyond 1.5 seen in cancer tissue and cancer
cell line DMH experiments have been used successfully to obtain
consistent information about regions with copy number effects,
especially if such measurements were observed at multiple
neighboring sites (unpublished data). Therefore it might also be
of interest to investigate DMH scores larger than 1.5 as found in
the mouse cell lines used in this study.
Comparison of ESCs, NSCs and embryonic brain identifies
differentially methylated genes during neural
differentiation
Many of the identified tDMRs may represent novel epigenetic
markers for neural cell differentiation. Among the genes associated
with tDMRs between ESCs and NSCs, many have a known
function in neural differentiation (i.e. Jag1, Tcf4) or have a function
related to the neural system (i.e. Mtap2, Slitrk1), which likely
supports a major role for DNA methylation in neural stem cell
differentiation that was unknown in most cases.
The genome-wide nature of our DMH analysis allowed not only
discovery of individual candidate markers, but also of groups of
genes which presumably act coordinately, and which were
characterized by functional epigenetic signatures defining a
particular differentiation stage. For example, genes associated
with tDMRs in NSCs and ESCs shared common GO annotations
(Supplementary Table S3). GO groups overrepresented in genes
highly methylated in ESCs, and therefore probably silenced, were
mainly related to brain and neural system development (e.g.
GOID 7399 and GOID 7420). These findings support our
hypothesis of DNA methylation playing a major functional role in
neural development, acting on individual genes and molecular
pathways. Interestingly, GO groups overrepresented in genes
highly methylated in NSCs were related to lipid metabolic process
(GOID 6629) and nucleoside-triphosphatase activity (GOID
17111). It has been suggested that the interplay between
metabolites of glycerophospholipid and sphingolipid metabolism
may play an important role in neural cell differentiation [28]. Our
data suggest that this interplay may be regulated through
differential DNA methylation.
Taken together, our findings emphasize the functional nature of
DNA methylation during cell differentiation and, more specifically,
in neural cell differentiation. The discovery of novel tDMRs during
differentiation from pluripotent embryonic stem cells to terminally
differentiated tissues provides attractive candidates for more
detailed functional studies of key drivers of neural cell development.
Materials and Methods
Ethical statement
Adult and embryo mice tissues were kindly provided by Dr.
Edith Heard (CNRS Institute Curie, Paris). Husbandry, housing
and experiments of animals comply with the French legislation
and the European regulations for the Protection of Vertebrate
Animals used for Experimental and other Scientific Purposes. The
institution is approved to carry out animal work and the personnel
handling the animals have been trained and licensed accordingly.
All the work with animals has been done at the Specified Pathogen
Free central mouse facility at the Institut Curie. This facility has
been accredited by the French National Authority (Accreditation
number #B75-05-18). Further ethical approval was not necessary
as the study did not require in-vivo experimentation, but the
molecular study of tissues obtained from sacrificed animals and
established murine cell lines.
Samples
Mouse tissue and DNA isolation. Adult mice were
euthanized and organs (spleen, kidney, liver and heart) were
dissected. Embryonic mice were 13.5 days old and 4 tissues were
dissected (limbs, spinal cord, forebrain and hindbrain). All adult
and embryonic tissues were obtained from F1 (C57BL/66DBA/
2J) mice. Adult mice DNA samples were taken from one mouse,
while embryonic DNA corresponds to pools of 5 to 8 embryos.
DNA was isolated from embryonic and adult mouse tissue using
the MinElute kit (Qiagen, Hilden, Germany).
Cell culture, in vitro differentiation. For the analysis of
ESCs, we used an already established murine cell line (E14)
derived from C57BL/6 mice [29]. Cell culture, differentiation
Figure 5. DMH and MeDIP-chip DNA methylation profiles in NSCs and ESCs. Both technologies showed similar results for two genes
involved in neural differentiation. A) Location of probes covering the investigated regions in the Pou5f1 (upper panel) and Ddah2 (lower panel) genes.
Red and green boxes represent areas covered by features in the DMH and MeDIP-chip arrays, respectively. B) DNA methylation values in Pou5f1 and
Ddah2 genes in NSCs and ESCs. DNA methylation values obtained with DMH (left panel) and MeDIP-chip (red panel) are comparable. Rows
correspond to features in the DMH or MeDIP-chip array and columns correspond to samples (NSCs (n=2) and ESCs (n=2)), grouped for DMH and
MeDIP-chip respectively. Quantitative methylation values are expressed as methylation percent for DMH and MeDIP-chip respectively and color-
coded as in Figure 2.
doi:10.1371/journal.pone.0026002.g005
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described [11].
Differential Methylation Hybridization – DMH
DNA from each biological sample was split into two aliquots
and both aliquots were processed in parallel. These two
technical replicates were then hybridized to two arrays. Each
pair of replicates showed a high correlation (mean R-squared
value=0.9729+/20.0136). DMH scores used for further
analysis were calculated using the averaged signals of the two
technical replicates. DNA methylation profiles in NSC and
ESC were assessed in two independent cultures for each cell
type. The embryonic tissue group consisted of limbs (n=1),
spinal cord (n=1), hindbrain (n=2) and forebrain (n=1). The
adult tissues group consisted of 4 different tissues: liver (n=1),
spleen (n=1), kidney (n=1) and heart (n=1). Pairs of
biological replicates, when available, also showed high corre-
lation in their respective DMH scores (R-squared val-
ues=0.8955, 0.7903 and 0.8852 for NSC, ESC and hindbrain,
respectively).
Hypermethylated regions were enriched using DMH as
originally described by Huang et al. [14] and further optimized
for the hybridization to high coverage Affymetrix human custom
arrays [15,16]. Briefly, genomic DNA was fragmented using a
cocktail of DNA methylation- insensitive restriction enzymes
(Csp6I, MseI and BfaI) and adaptors were ligated to the generated
ends. The adaptors were prepared by annealing the two oligos
(59-AGGCAACTGTGCTATCCGAGGGAT-39 and 59-TAAT-
CCCTCGGA-39). Next, fragments were digested using a
cocktail of DNA methylation-sensitive restriction enzymes
(BstUI, HpaII, HinP1I and HpyCH4IV), which cleave unmethy-
lated sites while leaving methylated sites intact such that
subsequent PCR with primers complementary to the adaptors
amplifies only the intact fragments. PCR products are then
hybridized to microarrays.
In this work, we used a newly developed Affymetrix mouse
array. This array was custom-designed (Affymetrix CustomSeqH)
and contained 51,243 probesets, with each probeset consisting of
8–10 individual probes. The mouse DMH array was designed
containing orthologous regions to the human DMH array in
order to enable also human-mouse comparative studies. The
probesets cover CpG-rich loci in 59-untranslated regions, exons
and introns of known genes, as well as in intergenic regions,
across all murine chromosomes. Approximately 50% of the
probes are located in know promoter regions. Furthermore, the
array contains probesets for loci that do not contain any relevant
methylation-sensitive restriction sites serving as internal calibra-
tion controls in addition to Affymetrix-designed control oligos.
Data were analyzed according to the methods previously
described [15,16]. All microarray data is MIAME compliant
and it has been deposited in the ArrayExpress database
(Accession Number: E-MTAB-576)
Direct Bisulfite Sequencing – DBS
Genomic DNA was bisulfite converted and PCR amplified as
previously described [4]. Bisulfite-specific primers with a minimum
length of 18 bp were designed using a modified Primer3 program
[30]. Primer sequences are given in Supplementary Table S4. The
target sequence of the designed primers contained no CpGs
allowing an unbiased amplification of both unmethylated and
methylated DNAs. Primers were also tested for specificity by
electronic PCR (ePCR) [31]. PCR amplicons from bisulfite treated
products were quality controlled by agarose gel electrophoresis,
purified with ExoSAP-IT (USB Corporation, Cleveland OH,
USA) to remove any excess nucleotides and primers, and
sequenced directly in forward and reverse directions. For
sequencing, we used the same primers as in the amplification
reaction. Sequencing was performed on an ABI 3730 capillary
sequencer using 1/20th dilution of ABI Prism BigDye terminator
V3.1 sequencing chemistry. The PCR amplification profile was:
Hotstart at 96uC for 30 seconds followed by 44 cycles of 92uC for
5 seconds, 50uC for 5 seconds and 60uC for 120 seconds. Before
injection, products were purified on DyeEx plates (Qiagen,
Hilden, Germany). The obtained sequencing chromatograms
were used to quantify the methylation at given CpGs as previously
described [4,18,19].
For each selected candidate tDMR, 2 amplicons were designed
and each covered at least one restriction site contained in the
corresponding DMH feature. The quality of the amplicons was
evaluated by assessing the quality of the bisulfite sequencing reads
first on technical DNA and the completeness of amplicon
coverage. The better performing amplicon for each tDMR was
then selected for the panel of amplicons for the validation
analysis.
Methylated DNA Immunoprecipitation and array
hybridization – MeDIP-chip
Methylated DNA Immunoprecipitation was performed of DNA
isolated from ESCs and NSCs according to standard protocols
[32]. For the array analysis, we used a custom tiling array
(NimbleGen) of mouse chromosome 17. The array comprised
,385,000 isothermal probes with an average size of 50 bases, tiled
at 100 base pair intervals. The tiling path was constructed for 2 kb
windows that contained less than 20% repeat elements and at least
1% CpG density. The microarrays were processed and analyzed
as described previously [33].
MAPPFinder
MAPPFinder was used to correlate microarray data of
differentially expressed genes to pathways annotated in Gen-
MAPP and to Gene Ontology (GO) annotations [17]. This
software calculates a cumulative total of genes changed for a
pathway or GO group and assigns a statistical value, the
Z-score.
Supporting Information
Table S1 tDMRs and their associated genes.
(XLS)
Table S2 tDMR-associated genes in ESCs, NSCs, and
embryonic brain.
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Table S3 MAPPFinder results for over-represented GO
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Table S4 Primer sequences for direct bisulfite sequenc-
ing (DBS).
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